About 1 in 9 people on the top dose (11.3%) stopped because of side effects, compared with 4.9% on placebo
District Court for the Northern District of Georgia before Judge Sarah Geraghty
By contrast, tight junction barrier loss can be reversed by targeted interventions
It is studied in laboratory research for its role in fat oxidation, lipolysis, adipose tissue metabolism, lipogenesis inhibition, and cartilage repair pathway biology without the IGF-1 stimulation, insulin resistance, or receptor-mediated proliferative effects associated with full-length hGH
Long-term success is more likely when GLP-1s are paired with a comprehensive care approach that includes clinical oversight, nutrition support, and long-term behavior change strategies